Marburg, Germany

Kathrin Koerner

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathrin Koerner. Retrieved from https://idiyas.com/inventor/kathrin-koerner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kathrin Koerner: Innovator in Gene Promoter Research

Introduction

Kathrin Koerner is a notable inventor based in Marburg, Germany. She has made significant contributions to the field of genetic research, particularly in the area of gene promoters. Her work has implications for pharmaceutical development and gene therapy.

Latest Patents

Kathrin holds a patent for the "Promoter of the cdc25B gene, its preparation and use." This invention provides a method for identifying cdc25B promoters and outlines their application in preparing pharmaceuticals. This patent highlights her innovative approach to genetic research and its potential applications in medicine. She has 1 patent to her name.

Career Highlights

Throughout her career, Kathrin has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. Her work there has allowed her to explore the intersection of genetics and drug development, contributing to advancements in the field.

Collaborations

Kathrin has collaborated with esteemed colleagues, including Rolf Mueller and Hans-Harald Sedlacek. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Kathrin Koerner's contributions to gene promoter research exemplify the impact of innovative thinking in the pharmaceutical industry. Her work continues to pave the way for advancements in genetic therapies and drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…